Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional - and often ineffective - advice to "eat ...
A Citigroup report predicts global uptake of weight loss drugs like Ozempic will reach hundreds of millions by 2035. Here's ...
Less than 10% of the millions eligible for the so-called "King Kong of weight loss drugs" will be able to get it in the next ...
The state pharmacy board placed two Nevada pharmacists on probation after they dispensed faulty weight loss drugs to local ...
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...
CEO of UnitedHealthcare shot and killed in New York; More snow predicted for hard-hit Great Lakes region; New study compares the effectiveness of popular weight loss drugs; and more on tonight’s ...
A study of two popular weight loss drugs, Zepbound and Wegovy, found that Zepbound was more effective helping people lose ...
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...
Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says ...
Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical ...